Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain

The excitatory neurotransmitter, glutamate, is particularly important in the transmission of pain information in the nervous system through the activation of ionotropic and metabotropic glutamate receptors. A potent, subtype-selective antagonist of the metabotropic glutamate-5 (mGlu5) receptor, 2-methyl-6-(phenylethynyl)-pyridine (MPEP), has now been discovered that has effective anti-hyperalgesic effects in models of inflammatory pain. MPEP did not affect rotarod locomotor performance, or normal responses to noxious mechanical or thermal stimulation in naïve rats. However, in models of inflammatory pain, systemic administration of MPEP produced effective reversal of mechanical hyperalgesia without affecting inflammatory oedema. In contrast to the non-steroidal anti-inflammatory drugs, indomethacin and diclofenac, the maximal anti-hyperalgesic effects of orally administered MPEP were observed without acute erosion of the gastric mucosa. In contrast to its effects in models of inflammatory pain, MPEP did not produce significant reversal of mechanical hyperalgesia in a rat model of neuropathic pain.

[1]  S. Heinemann,et al.  Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems , 1999, Nature Neuroscience.

[2]  W. Zieglgänsberger,et al.  mGluR activation reveals a tonic NMDA component in inflammatory hyperalgesia , 1998, Neuroreport.

[3]  Ronald Dubner,et al.  A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury , 1990, Pain.

[4]  T. Salt,et al.  Reduction of sensory and metabotropic glutamate receptor responses in the thalamus by the novel metabotropic glutamate receptor-1-selective antagonist S-2-methyl-4-carboxy-phenylglycine , 1998, Neuroscience.

[5]  T. Salt,et al.  The function of metabotropic excitatory amino acid receptors in synaptic transmission in the thalamus: Studies with novel phenylglycine antagonists , 1994, Neurochemistry International.

[6]  E. Bradley,et al.  Sedative and Hypnotic Midazolam‐Morphine Interactions in Rats , 1990, Anesthesia and analgesia.

[7]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .

[8]  D. Laurie,et al.  Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation , 1997, Neuroscience.

[9]  T. Salt,et al.  Mediation of Thalamic Sensory Responses In Vivo by ACPD‐activated Excitatory Amino Acid Receptors , 1993, The European journal of neuroscience.

[10]  A. N. van den Pol,et al.  Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: Protein, mRNA splice variants, and regional distribution , 1996, The Journal of comparative neurology.

[11]  J. Hunter,et al.  The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. , 1997, European journal of pharmacology.

[12]  M. J. Johnson,et al.  Antisense Ablation of Type I Metabotropic Glutamate Receptor mGluR1 Inhibits Spinal Nociceptive Transmission , 1998, The Journal of Neuroscience.

[13]  T. Salt,et al.  Mediation of thalamic sensory input by both NMDA receptors and non-NMDA receptors , 1986, Nature.

[14]  A. Fox,et al.  Animal models for pain research. , 1999, Molecular medicine today.

[15]  Y. Smith,et al.  Activation of N‐Methyl‐D‐Aspartate Receptors Reverses Desensitization of Metabotropic Glutamate Receptor, mGluR5, in Native and Recombinant Systems , 1999, Annals of the New York Academy of Sciences.

[16]  G. Seabrook,et al.  Mobilisation of intracellular Ca2+ by mGluR5 metabotropic glutamate receptor activation in neonatal rat cultured dorsal root ganglia neurones , 2000, Neuropharmacology.

[17]  J. Valtschanoff,et al.  Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn , 1999, The Journal of comparative neurology.

[18]  A. Herz,et al.  Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds , 1988, Pharmacology Biochemistry and Behavior.

[19]  M. Randić,et al.  Modulation of AMPA and NMDA responses in rat spinal dorsal horn neurons by trans-1-aminocyclopentane-1,3-dicarboxylic acid , 1992, Neuroscience Letters.

[20]  Roland Heckendorn,et al.  2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist , 1999, Neuropharmacology.

[21]  R. Coggeshall,et al.  Opioid receptors on peripheral sensory axons , 1997, Brain Research.

[22]  M. Memo,et al.  mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study , 1997, Neuroscience Research.

[23]  C. Torrance,et al.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. , 1992, The New England journal of medicine.

[24]  T. Coderre,et al.  The contribution of metabotropic glutamate receptors (mGluRs) to formalin-induced nociception , 1996, Pain.

[25]  A. N. van den Pol,et al.  Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain , 1995, The Journal of comparative neurology.

[26]  T. Coderre,et al.  Hyperalgesia and allodynia induced by intrathecal (RS)‐dihydroxyphenylglycine in rats , 1998, Neuroreport.

[27]  G. Guilbaud,et al.  The enhancement of morphine antinociception by a CCKB receptor antagonist in the rat depends on the phase of inflammation and the intensity of carrageenin-induced hyperalgesia , 1998, Pain.

[28]  S. Wakisaka,et al.  Regeneration of periodontal primary afferents of the rat incisor following injury of the inferior alveolar nerve with special reference to neuropeptide Y-like immunoreactive primary afferents , 1997, Brain Research.

[29]  C. Cahill,et al.  Intrathecal administration of the mGluR compound, (S)-4CPG, attenuates hyperalgesia and allodynia associated with sciatic nerve constriction injury in rats , 1998, Pain.

[30]  R. Miller,et al.  Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn. , 1992, Molecular pharmacology.

[31]  T. Salt,et al.  Evaluation of agonists and antagonists acting at Group I metabotropic glutamate receptors in the thalamus in vivo , 1999, Neuropharmacology.

[32]  László Négyessy,et al.  Cellular, and subcellular localization of the mGluR5a metabotropic glutamate receptor in rat spinal cord , 1994, Neuroreport.

[33]  W. Willis,et al.  Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells. , 1999, Journal of neurophysiology.

[34]  B. Cairns,et al.  Development of inflammation after application of mustard oil or glutamate to the rat temporomandibular joint. , 1999, Archives of oral biology.

[35]  A. Dickenson,et al.  The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. , 1997, General pharmacology.

[36]  F. Gasparini,et al.  Antagonism of the mGlu5 agonist 2‐chloro‐5‐hydroxyphenylglycine by the novel selective mGlu5 antagonist 6‐methyl‐2‐(phenylethynyl)‐pyridine (MPEP) in the thalamus , 1999, British journal of pharmacology.

[37]  A. Young,et al.  Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5 , 1995, Neuropharmacology.

[38]  W. Zieglgänsberger,et al.  Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord. , 1999, Brain research. Developmental brain research.

[39]  T. Coderre,et al.  Comparison of nociceptive effects produced by intrathecal administration of mGluR agonists. , 1996, Neuroreport.

[40]  D. Jane,et al.  Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.

[41]  H. Schaible,et al.  Requirement of Metabotropic Glutamate Receptors for the Generation of Inflammation‐evoked Hyperexcitability in Rat Spinal Cord Neurons , 1994, The European journal of neuroscience.

[42]  K. Stauderman,et al.  Fluorescence techniques for measuring ion channel activity. , 1999, Methods in enzymology.

[43]  G. Baranauskas,et al.  SENSITIZATION OF PAIN PATHWAYS IN THE SPINAL CORD: CELLULAR MECHANISMS , 1998, Progress in Neurobiology.

[44]  F. Gasparini,et al.  SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. , 1999, The Journal of pharmacology and experimental therapeutics.